Kenneth graduated with a Bachelor of Medicine from Monash University, Australia. After completing his clinical internship in Australia, he joined Bayer in Malaysia as a Medical Science Liaison in August 2011 and undertook roles of increasing responsibilities within medical affairs. In 2015, he was the Associate Medical Director for Malaysia before he moved to Singapore in 2016 to take on the position of Regional Medical Advisor, Cardiovascular & Thrombosis for Asia Pacific.In October 2018, he transitioned into the role of Country Medical Director, Singapore/Malaysia/Brunei in Bayer.Over the past 2 years, Kenneth has had experience analyzing and appraising various RWE publications in the area of Thrombosis. He is also the co-author of the XANAP prospective observational study1 in Asia Pacific.